Jennifer Schranz
2019
In 2019, Jennifer Schranz earned a total compensation of $982.2K as Chief Medical Officer at Nabriva Therapeutics AG.
Compensation breakdown
| Non-Equity Incentive Plan | $151,200 |
|---|---|
| Option Awards | $261,555 |
| Salary | $436,200 |
| Stock Awards | $99,750 |
| Other | $33,450 |
| Total | $982,155 |
Schranz received $436.2K in salary, accounting for 44% of the total pay in 2019.
Schranz also received $151.2K in non-equity incentive plan, $261.6K in option awards, $99.8K in stock awards and $33.5K in other compensation.
Rankings
In 2019, Jennifer Schranz's compensation ranked 9,354th out of 13,971 executives tracked by ExecPay. In other words, Schranz earned more than 33.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,354 out of 13,971 | 33rd |
Division Manufacturing | 3,753 out of 5,695 | 34th |
Major group Chemicals And Allied Products | 1,425 out of 2,194 | 35th |
Industry group Drugs | 1,214 out of 1,880 | 35th |
Industry Pharmaceutical Preparations | 901 out of 1,392 | 35th |
Source: SEC filing on June 25, 2020.
Schranz's colleagues
We found two more compensation records of executives who worked with Jennifer Schranz at Nabriva Therapeutics AG in 2019.